UNAIR Inactivated COVID-19 Vaccine as Heterologue Booster (Immunobridging Study)

Clinical trial NCT05918939 · UNKNOWN

Trial details

NCT number: NCT05918939
Sponsor: Dr. Soetomo General Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

COVID-19 Pandemic COVID-19 Vaccines

Start date: 2022-09-05
Primary completion: 2023-08-05
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.